|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/06 | (1974.07) |
| C07D 401/14 | (1974.07) |
| (11) | Number of the document | 3710439 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18879484.6 |
| Date of filing the European patent application | 2018-11-14 | |
| (97) | Date of publication of the European application | 2020-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2023-02-15 |
| (46) | Date of publication of the claims translation | 2023-05-10 |
| (86) | Number | PCT/US2018/061060 |
| Date | 2018-11-14 |
| (87) | Number | WO 2019/099524 |
| Date | 2019-05-23 |
| (30) | Number | Date | Country code |
| 201762586775 P | 2017-11-15 | US |
| (72) |
BLAKE, James, F. , US
BURGESS, Laurence, E. , US
CHICARELLI, Mark, Joseph , US
CHRISTENSEN, James, Gail , US
COOK, Adam , US
FELL, Jay, Bradford , US
FISCHER, John, P. , US
MARX, Matthew, Arnold , US
MEJIA, Macedonio, J. , US
SAVECHENKOV, Pavel , US
VIGERS, Guy, P.A. , US
SMITH, Christopher, Ronald , US
RODRIGUEZ, Martha, E. , US
TANG, Tony Pisal , US
|
| (73) |
Mirati Therapeutics, Inc. ,
9393 Towne Centre Drive
Suite 200, San Diego, CA 92121,
US
Array Biopharma Inc. , 3200 Walnut Street, Boulder, CO 80301, US |
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | KRas G12C inhibitoriai |
| KRAS G12C INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2024-10-04 | 7 | 162.00 EUR |
| 2025-11-14 |